The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

Hospitalization rates from respiratory syncytial virus (RSV) infection rose with age. Also, hospitalizations were more likely among nursing home residents and older adults with other health issues, ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, and ...

CI: confidence interval; COPD: chronic obstructive pulmonary disease; NA: not applicable. a Rate ratio and 95% confidence interval obtained from a Poisson regression analysis adjusted for sex, 5 ...

RSV, a common and contagious virus that affects the lungs and respiratory airways, that can affect people of all ages, from infants to adults. Among adults, it disproportionately affects older adults ...

Get Instant Summarized Text (Gist) In Spain, RSV hospitalization rates among older adults increase with age and are higher in those with certain health conditions or living in nursing homes. The ...